| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥92.0B | ¥98.0B | -6.2% |
| Operating Income | ¥8.0B | ¥7.9B | +1.1% |
| Ordinary Income | ¥8.7B | ¥7.5B | +16.3% |
| Net Income | ¥6.9B | ¥5.3B | +30.9% |
| ROE | 6.8% | 5.9% | - |
FY2026 Q2 results: Revenue 92.0B yen (YoY -6.2%), Operating Income 8.0B yen (+1.1%), Ordinary Income 8.7B yen (+16.3%), Net Income 6.9B yen (+30.9%). The company achieved a revenue down/profit up pattern, with operating margin improving to 8.7% from 8.1% YoY despite the revenue decline. The profit growth was driven by strong non-operating performance including FX gains of 0.9B yen and robust cost control. Basic EPS increased 23.8% to 210.11 yen. Operating cash flow surged 34.7% to 13.1B yen, demonstrating improved cash generation capability with OCF/Net Income ratio of 2.07x. Total assets expanded to 201.1B yen from 177.8B yen, while equity strengthened to 102.5B yen from 89.3B yen. Cash position increased significantly by 17.8B yen (+32.2%) to 73.1B yen, enhancing financial flexibility.
Revenue declined 6.2% YoY to 92.0B yen, impacted by weak performance across most geographic segments. By region, Southeast Asia/South Asia contributed 31.2B yen (-12.4% YoY), representing the largest revenue source. Japan segment generated 29.3B yen (-3.1% YoY), China segment 21.9B yen (-1.2% YoY), and Europe and America segment 13.3B yen (-4.1% YoY). Revenue from goods transferred at a point in time decreased to 91.3B yen from 97.1B yen, while service revenue over time declined to 0.7B yen from 0.9B yen. The broad-based regional weakness suggests cyclical demand softness or competitive pressure rather than company-specific issues.
Operating income increased marginally by 1.1% to 8.0B yen despite the revenue decline, reflecting effective cost management. Operating margin improved by 0.6 percentage points to 8.7% from 8.1% YoY. Gross profit margin expanded to 31.8% from 29.8% YoY, indicating improved product mix or pricing power. SG&A expenses decreased in absolute terms to 21.2B yen from 21.4B yen, with the SG&A ratio declining to 23.1% from 21.8%. R&D expense remained minimal at 0.1B yen (0.1% of revenue). Depreciation and amortization totaled 4.1B yen, down from 4.3B yen YoY.
Ordinary income outpaced operating income growth with a 16.3% increase to 8.7B yen, driven by significant non-operating gains. The non-operating net contribution was 0.7B yen positive, compared to a 0.4B yen loss in the prior year, representing a favorable swing of 1.1B yen. FX gains of 0.9B yen (versus 0.2B yen FX loss last year) contributed significantly. Interest expense remained controlled at 0.7B yen. The gap between ordinary income (8.7B yen) and operating income (8.0B yen) of 0.7B yen reflects the net benefit from financial activities.
Net income surged 30.9% to 6.9B yen, significantly outpacing ordinary income growth due to extraordinary gains and a lower effective tax rate. Extraordinary income totaled 1.1B yen with no material extraordinary losses. The effective tax rate was 28.6% (2.8B yen tax expense on 9.8B yen pretax income), compared to 33.4% in the prior year, contributing approximately 0.3B yen to net income improvement. Non-controlling interests absorbed 0.6B yen, resulting in 6.3B yen attributable to parent company shareholders.
This represents a revenue down/profit up pattern, where operational efficiency improvements and favorable financial factors more than compensated for top-line weakness. The sustainability of this pattern depends on revenue stabilization, as continued margin expansion has natural limits.
Southeast Asia/South Asia segment generated revenue of 31.2B yen (-12.4% YoY) with operating income of 4.0B yen (-0.4% YoY) and margin of 13.0%, representing the largest and most profitable segment with approximately 34% of total revenue. This core business maintained profitability despite revenue headwinds, indicating resilient demand fundamentals or successful pricing strategies.
Japan segment produced revenue of 29.3B yen (-3.1% YoY) with operating income of 1.0B yen (-50.3% YoY) and margin of 3.5%, the lowest among all segments. The sharp profit decline from 2.1B yen to 1.0B yen despite modest revenue decrease signals operational challenges or competitive pressure in the domestic market. The company acquired all shares of Hep Promotion Co., Ltd. in December 2025, generating 62.5M yen of goodwill, which may contribute to future performance but also introduces integration risks.
China segment achieved revenue of 21.9B yen (-1.2% YoY) with operating income of 1.7B yen (versus 0.0B yen YoY) and margin of 7.6%, showing dramatic profitability recovery. The turnaround from near-breakeven to 1.7B yen profit represents the most significant operational improvement across all segments, suggesting successful restructuring or market recovery.
Europe and America segment recorded revenue of 13.3B yen (-4.1% YoY) with operating income of 1.2B yen (-28.1% YoY) and margin of 9.2%. Profitability declined from 1.7B yen to 1.2B yen, indicating margin pressure from either competitive dynamics or cost inflation in developed markets.
The geographic diversification provides risk mitigation, but the simultaneous weakness across most regions suggests systemic challenges. Southeast Asia/South Asia's dominance at 13.0% margin versus Japan's 3.5% margin highlights material profitability differences by geography. The China segment's recovery is encouraging, while Japan's deterioration warrants strategic attention.
[Profitability] ROE of 6.8% is calculated based on net income of 6.9B yen and total equity of 102.5B yen, representing shareholders' return on invested capital. Operating margin of 8.7% improved from 8.1% YoY, demonstrating operational efficiency gains despite revenue headwinds. Net profit margin of 7.5% expanded significantly from 5.4% YoY, reflecting both operational improvements and favorable non-operating factors including FX gains and lower tax rates. Gross profit margin of 31.8% improved from 29.8% YoY, indicating successful cost management or improved product mix. The company generated operating income of 8.0B yen on revenue of 92.0B yen with SG&A expenses of 21.2B yen (23.1% of revenue). [Cash Quality] Cash and deposits of 73.1B yen increased 32.2% from 55.3B yen YoY, providing substantial liquidity buffer. Short-term debt coverage stands at 2.87x, calculated as cash divided by current portion of long-term debt and short-term borrowings totaling 25.5B yen. Operating cash flow of 13.1B yen represents 2.07x net income, confirming strong cash-backed earnings quality. Free cash flow of 10.7B yen (operating CF of 13.1B yen minus CapEx of 2.4B yen) demonstrates robust cash generation after capital expenditures. Working capital shows signs of deterioration with accounts receivable increasing while accounts payable decreased, extending the cash conversion cycle. [Investment Efficiency] Total asset turnover of 0.46x (revenue of 92.0B yen divided by total assets of 201.1B yen) indicates moderate asset utilization efficiency. Inventory turnover days of 40 days and receivables turnover days of 106 days result in a cash conversion cycle of 139 days, with receivables collection showing room for improvement. Capital expenditure of 2.4B yen relative to depreciation of 4.1B yen yields a CapEx/depreciation ratio of 0.58x, suggesting underinvestment in asset renewal and potential future constraints on growth capacity. Return on assets of 3.4% reflects moderate profitability relative to total asset base. [Financial Health] Equity ratio of 51.0% (equity of 102.5B yen divided by total assets of 201.1B yen) indicates stable financial structure. Current ratio of 206.3% (current assets of 122.1B yen divided by current liabilities of 59.2B yen) demonstrates strong short-term liquidity. Debt-to-equity ratio of 0.46x (interest-bearing debt of 47.4B yen divided by equity of 102.5B yen) remains at moderate levels. Interest-bearing debt totals 47.4B yen, comprising long-term loans of 21.9B yen, bonds payable of 4.6B yen, current portion of bonds of 1.8B yen, and short-term borrowings estimated at 25.5B yen less disclosed items. Net debt of 47.4B yen minus cash of 73.1B yen results in net cash position of 25.7B yen, indicating no net leverage. The company maintains defined benefit pension liabilities of 6.7B yen and deferred tax assets of 3.9B yen.
Operating cash flow of 13.1B yen increased 34.7% from 9.7B yen YoY, with OCF representing 2.07x net income of 6.3B yen (attributable to parent), confirming strong cash generation quality. The cash flow subtotal before working capital changes was 15.1B yen, indicating robust underlying earnings power. Working capital movements included a favorable receivables change of 2.6B yen inflow, minimal inventory change of 0.2B yen outflow, and an unfavorable payables change of 2.1B yen outflow, resulting in net working capital drain of approximately 0.3B yen. Income taxes paid of 1.5B yen and interest paid of 0.7B yen represent cash outflows for obligations. Interest and dividends received totaled 0.2B yen, contributing modest non-operating cash inflows. Investing cash flow of negative 2.4B yen consisted entirely of capital expenditures of 2.4B yen, with no material asset sales or acquisitions reflected in the period cash flow statement despite the acquisition of Hep Promotion Co., Ltd. noted in segment disclosures, suggesting possible timing differences or non-cash consideration. Financing cash flow of positive 3.1B yen reflected capital management activities including share repurchases of 1.5B yen, with the net positive financing CF suggesting debt issuance or refinancing activities that increased overall borrowings. Free cash flow of 10.7B yen (operating CF of 13.1B yen minus investing CF of 2.4B yen) demonstrates substantial cash generation capacity after investment needs, providing ample resources for shareholder returns and debt service. The cash position increased by approximately 17.8B yen from 55.3B yen to 73.1B yen, with the increase exceeding the sum of operating, investing, and financing flows due to comprehensive income effects including foreign exchange translation adjustments of 8.8B yen that boosted consolidated cash positions.
Ordinary income of 8.7B yen versus operating income of 8.0B yen shows non-operating net contribution of approximately 0.7B yen, primarily from foreign exchange gains. This comprises interest income of 0.1B yen, FX gains of 0.9B yen, and other non-operating income of 0.2B yen, offset by interest expense of 0.7B yen, FX losses of 0.2B yen, and other non-operating expenses of 0.1B yen. Non-operating income represents 1.6% of revenue, consisting of recurring financial income and FX gains that can fluctuate with currency movements. The FX gain of 0.9B yen represents a significant swing from prior year FX loss of 0.2B yen, contributing approximately 1.1B yen to the favorable variance in ordinary income. This FX sensitivity reflects the company's geographic revenue diversification, with 66% of revenue from overseas markets. Operating cash flow of 13.1B yen substantially exceeds net income of 6.9B yen, yielding an OCF/NI ratio of 1.90x when including non-controlling interests, indicating earnings quality supported by strong cash generation. The gap between operating CF subtotal (15.1B yen) and reported net income (6.9B yen) of 8.2B yen reflects depreciation and amortization of 4.1B yen plus other non-cash items, confirming that a significant portion of earnings represents non-cash charges. Extraordinary income of 1.1B yen with minimal extraordinary losses suggests one-time gains that boosted net income, warranting adjustment for normalized earnings assessment. The effective tax rate of 28.6% was lower than the prior year, contributing to net income growth beyond operational improvements. Comprehensive income of 15.8B yen significantly exceeded net income of 6.9B yen due to FX translation adjustments of 8.8B yen, reflecting balance sheet revaluation effects rather than cash earnings, and should be viewed as volatility in reported equity rather than distributable earnings quality.
Progress rate versus full-year guidance shows revenue at 52.1% (92.0B yen of 176.7B yen target), operating income at 65.4% (8.0B yen of 12.2B yen target), and ordinary income at 73.1% (8.7B yen of 11.9B yen target) through Q2. Revenue progress aligns closely with the standard 50% benchmark for H1, suggesting on-track performance. Operating income progress of 65.4% exceeds the 50% standard by 15.4 percentage points, indicating strong first-half profitability that may reflect seasonality or front-loaded project completions. Ordinary income progress of 73.1% substantially exceeds the standard rate, driven by the significant FX gains of 0.9B yen in the period which may not repeat in H2, suggesting potential for full-year ordinary income to exceed guidance if favorable conditions persist. The company maintained its full-year guidance with no revisions this quarter, projecting revenue of 176.7B yen (YoY -5.9%), operating income of 12.2B yen (-7.1%), ordinary income of 11.9B yen (+2.4%), and EPS of 272.30 yen. The forecast implies H2 revenue of 84.7B yen, operating income of 4.2B yen, and ordinary income of 3.2B yen, representing significant sequential deceleration from H1 performance levels. This conservative H2 outlook may reflect anticipated seasonal patterns, project timing, or management's prudent approach to volatile factors such as FX rates. Annual dividend forecast of 41.00 yen implies payout ratio of approximately 15.1% based on forecast EPS of 272.30 yen, remaining conservative relative to the company's cash generation capability. Forecast notes indicate the guidance is based on current available information and reasonable assumptions, with actual results subject to variation from multiple factors, and that management plans an institutional investor briefing on March 2, 2026 with materials to be posted on the corporate website.
Annual dividend forecast of 41.00 yen per share consists of interim dividend of 20.50 yen (already paid) and year-end dividend of 20.50 yen. Based on the prior period's dividend of 38.00 yen (19.00 yen interim plus 19.00 yen year-end), the forecast represents an increase of 3.00 yen (+7.9%) YoY. Payout ratio based on forecast EPS of 272.30 yen is 15.1%, remaining conservative and indicating substantial room for dividend growth. Payout ratio based on actual H1 EPS of 210.11 yen annualized would be approximately 9.8%, further confirming the sustainable and conservative nature of the dividend policy. Share buyback of 1.5B yen was executed during the period, demonstrating commitment to shareholder returns through capital reduction. Total return ratio combining dividends and buybacks relative to net income: assuming full-year net income reaches approximately 8.3B yen (based on guidance EPS of 272.30 yen times average shares), and dividends of approximately 1.3B yen (41.00 yen times 32.5M shares after treasury stock), plus buybacks of 1.5B yen in H1, the total return would be approximately 2.8B yen or 34% of forecast net income, indicating balanced capital allocation between retention for growth and returns to shareholders. The company maintains a prudent balance between accumulating cash reserves (73.1B yen) and returning capital, with the net cash position of 25.7B yen providing ample headroom for sustained or increased shareholder returns. Treasury stock holdings of 293K shares (8.3% of issued shares) reflect cumulative buyback activity.
Geographic revenue concentration risk with Southeast Asia/South Asia contributing 34% of revenue and showing 12.4% YoY decline. Any further deterioration in this core region would materially impact consolidated results, particularly given the segment's highest operating margin of 13.0%. Regional diversification provides partial mitigation, but simultaneous weakness across multiple geographies in the current period demonstrates limited insulation from global demand cycles.
Working capital efficiency deterioration with accounts receivable turnover extending to 106 days and cash conversion cycle lengthening to 139 days. The unfavorable receivables change of 2.6B yen inflow in operating cash flow indicates improved collection, but the days outstanding metric suggests structural lengthening of payment terms. If customer payment discipline weakens further or the company extends terms to support sales, this could constrain cash generation despite reported profitability growth.
Underinvestment risk with CapEx of 2.4B yen representing only 58% of depreciation of 4.1B yen, indicating insufficient asset renewal relative to consumption. This CapEx/depreciation ratio below 1.0x for sustained periods typically leads to aging asset base, potential capacity constraints, and eventual need for accelerated catch-up investment. The company's ability to maintain operational efficiency and support revenue growth may be compromised if this investment gap persists, with deferred maintenance or modernization potentially emerging as competitive disadvantage in the medium term.
Industry Position (Reference - Proprietary Analysis): The company's profitability metrics demonstrate competitive positioning within the manufacturing sector. Operating margin of 8.7% aligns closely with the industry median of 8.8% (Q2 2025, n=7), placing the company at industry-average operational efficiency. Net profit margin of 7.5% exceeds the industry median of 5.4% by 2.1 percentage points, indicating superior bottom-line conversion supported by favorable non-operating performance and tax effects. Return on equity of 6.8% compares favorably to the industry median of 4.4%, ranking in the upper half of peer performance despite moderate leverage utilization. Financial health indicators show solid positioning with equity ratio of 51.0% slightly above the industry median of 48.6%, demonstrating comparable financial stability. Current ratio of 206.3% falls below the industry median of 274% but remains well within healthy liquidity range, reflecting more efficient working capital deployment than highly conservative peers. Asset turnover of 0.46x exceeds the industry median of 0.36x by 28%, indicating superior asset utilization efficiency relative to manufacturing sector norms and compensating for the moderate ROE through operational leverage. Revenue growth of negative 6.2% YoY underperforms the industry median of positive 11.7%, placing the company in the bottom half of growth trajectories and representing the primary area of competitive concern. The industry interquartile range spans from negative 5.4% to positive 28.3%, positioning the company below the 25th percentile in top-line momentum. Operating working capital turnover days are not directly comparable with available segment data, but the cash conversion cycle appears aligned with industry practices. The company's financial leverage of 1.96x falls within the industry interquartile range of 1.51x to 3.63x, reflecting moderate capital structure. Overall, the company demonstrates operational efficiency and profitability comparable to or exceeding sector medians, with financial stability in line with industry standards, but faces relative weakness in revenue growth momentum that warrants strategic attention to market positioning and demand generation.
(Industry: Manufacturing sector, Comparison period: Q2 2025, Source: Proprietary analysis of publicly available earnings data)
Strong cash generation quality with operating cash flow of 13.1B yen representing 2.07x net income and free cash flow of 10.7B yen provides financial flexibility for capital allocation. The company's ability to convert earnings into cash at twice the rate of accounting profits, combined with a net cash position of 25.7B yen, demonstrates financial resilience and supports sustained shareholder returns. The current conservative payout ratio of 15.1% based on forecast earnings indicates substantial room for dividend growth or additional buybacks without straining liquidity, particularly given the robust FCF generation that comfortably covers both dividends and H1 share repurchases of 1.5B yen.
Profitability resilience amid revenue headwinds reflects operational discipline and structural margin improvement. Operating margin expansion to 8.7% from 8.1% YoY despite 6.2% revenue decline demonstrates the company's ability to adjust cost structure and preserve profitability through business cycles. The gross margin improvement to 31.8% from 29.8% suggests either improved product mix shift toward higher-value offerings or successful pricing discipline. This margin resilience pattern, if sustained, positions the company to generate strong earnings leverage when revenue growth resumes, though the sustainability depends on addressing the top-line weakness without compromising competitive positioning.
Working capital efficiency deterioration and underinvestment require monitoring as potential constraints on future growth. The extension of accounts receivable collection to 106 days and the CapEx/depreciation ratio of 0.58x indicate deferred investments in both customer credit management and physical asset base. While these factors have supported near-term cash flow and profitability, continued underinvestment in working capital optimization and capital assets may limit the company's ability to capture growth opportunities when demand recovers. The need to eventually address these deferrals could result in lumpy cash flow patterns or margin pressure in future periods as catch-up investment becomes necessary to maintain competitive capabilities and operational infrastructure.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.